Company: SNPS
Filing Date: 2025-06-30
Form Type: 425
Source: 0001140361-25-024106
Chunk: 2

Company: SYNOPSYS INC
Filing Date: 2025-06-30
Form: 425
Chunk 2
---
 Ansys’ or Synopsys’ business relationships, competition, business, financial condition, and
          operating results, (vi) risks that the proposed transaction disrupts current plans and operations of Ansys or Synopsys and the ability of Ansys or Synopsys to retain and hire key personnel, (vii) risks related to diverting either management
          team’s attention from ongoing business operations of Ansys or Synopsys, (viii) the outcome of any legal proceedings that may be instituted against Ansys or Synopsys related to the merger agreement or the proposed transaction, (ix) the ability of
          Synopsys to successfully integrate Ansys’ operations and product lines, (x) the ability of Synopsys to implement its plans, forecasts, expected financial performance and other expectations with respect to Ansys’ business or the combined business
          after the completion of the proposed transaction and realize the benefits expected from the proposed transaction (if completed), as well as manage the scope and size of the combined company, (xi) risks associated with third party contracts
          containing consent and/or other provisions that may be triggered by the proposed transaction, (xii) uncertainty in the macroeconomic and geopolitical environment and its potential impact on the semiconductor and electronics industries, (xiii)
          uncertainty in the growth of the semiconductor, electronics and artificial intelligence industries, (xiv) the highly competitive industries in which Synopsys and Ansys operate, (xv) actions by the U.S. or foreign governments, such as the
          assessment of fines or the imposition of additional export restrictions or tariffs, (xvi) the evolving legal, regulatory and tax regimes under which Ansys and Synopsys operate, and (xvii) restrictions during the pendency of the proposed
          transaction that may impact Ansys’ or Synopsys’ ability to pursue certain business opportunities or strategic transactions.**

<div align='center'>2</div>

These risks, uncertainties and factors, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus filed with the SEC in connection with the proposed transaction. While the list
          of risks, uncertainties and factors presented here, and the list of risks presented in the proxy statement/prospectus, are considered representative, no such list is exhaustive. Unlisted risks, uncertainties and factors may present significant
          additional obstacles to the realization of forward-looking statements.

You should carefully consider the foregoing factors and the other risks and uncertainties that